FDA NDC Directory · JSON-LD · Markdown

Paliperidone

NDC 27241-276 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerAjanta Pharma USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA218514
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsPALIPERIDONE (1.5 mg/1)
Marketing started20240626
Package count1

External sources

Source: openFDA. Public-domain (CC0).